Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject.
D000138:Acidosis / Q000209:etiology; D000251:Adenosine Triphosphatases / Q000096:biosynthesis; D000255:Adenosine Triphosphate / Q000097:blood*; D000328:Adult; D000535:Aluminum; D000740:Anemia / Q000209:etiology; D000863:Antacids / Q000009:adverse effects; D001639:Bicarbonates / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003677:Deficiency Diseases; D004032:Diet; D004912:Erythrocytes / Q000378:metabolism*; D005782:Gels; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D010710:Phosphates / Q000097:blood*; D010758:Phosphorus / Q000097:blood; D006435:Renal Dialysis; D014511:Uremia / Q000150:complications*
D000863:Antacids; D001639:Bicarbonates; D005782:Gels; D010710:Phosphates; D010758:Phosphorus; D000255:Adenosine Triphosphate; D003404:Creatinine; D000535:Aluminum; D000251:Adenosine Triphosphatases